Kristian Reich, MD, PhD

Kristian Reich, MD, PhD, is the founder and chief scientific officer of MoonLake Immunotherapeutics.

Articles by Kristian Reich, MD, PhD

HiSQOL Scores, Avidity, and the Case for Dual IL-17 Inhibition in Hidradenitis Suppurativa

ByChristopher G. Bunick, MD, PhD,Kristian Reich, MD, PhD,Kaitlyn Bader, Assistant Managing Editor

April 7th 2026

Christopher Bunick, MD, PhD, and Kristian Reich, MD, PhD, discuss phase 3 data presented at AAD showing patients moving from very severe disease at baseline to absent or mild disease by week 40.

Sonelokimab Demonstrates High HiSCR100 Rates and Durable Responses in Hidradenitis Suppurativa

ByChristopher G. Bunick, MD, PhD,Kristian Reich, MD, PhD,Kaitlyn Bader, Assistant Managing Editor

March 28th 2026

Christopher Bunick, MD, PhD, and Kristian Reich, MD, PhD, discuss the long-term efficacy of sonelokimab, with more than 60% of patients achieving HiSCR75 and approximately 30% reaching HiSCR100.

Kristian Reich, MD, PhD

Articles by Kristian Reich, MD, PhD

HiSQOL Scores, Avidity, and the Case for Dual IL-17 Inhibition in Hidradenitis Suppurativa

Sonelokimab Demonstrates High HiSCR100 Rates and Durable Responses in Hidradenitis Suppurativa

Latest Updated Articles

Trending on Dermatology Times

FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years

Digital Twins in Dermatology: Your Patient’s Virtual Double Is Coming

Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show

Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging

Quality of Life in CSU Shaped by More Than Skin Symptoms